Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_4
1
13%
Ph phase_1
2
25%
Ph phase_2
1
13%
Ph not_applicable
1
13%
Ph phase_3
1
13%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

completed563%
unknown338%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

NCT05065905
unknown

A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis

NCT06118619
unknown

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis

NCT05359315
completednot_applicable

Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia

NCT05395702
completedphase_1

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

NCT02197169
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05065905Phase 1

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

Completed
NCT06118619

A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis

Unknown
NCT05359315

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis

Unknown
NCT05395702Not Applicable

Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia

Completed
NCT02197169Phase 1

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Completed
NCT00001317Phase 4

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

Completed
NCT00001296Phase 3

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Completed
NCT00244179Phase 2

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8